Ginger Johnson, PhD, President, Asset Optimization and Commercialization at Lumanity, formerly Cello Health BioConsulting, featured as a panelist in discussion, “Women in Biotechnology,” moderated by Karen Tkach Tuzman, Senior Editor, BioCentury.
Women in Biotech Progress – Yet Challenges Remain, Update on Female Innovators in Biotech
View
Sep 6, 2021
Related
2024 Neuroscience Recap: Key Breakthroughs and Developments
View
Dec 12, 2024
Joint Clinical Assessment – Anticipating your PICOs
View
Dec 10, 2024
The IRP Regulatory Pathway and its Implications for NICE
View
Dec 3, 2024
Transform Your Competitive Strategy
View
Dec 2, 2024
Are EU Member States Ready?
View
Dec 2, 2024
ISPOR Europe Diaries 2024
View
Nov 29, 2024
Using Real World Data to Guide Precision Oncology Drug Development
View
Nov 25, 2024